Myasthenia gravis

• A double-blind, randomised, placebo-controlled, first-in-human (FIH) Phase I/IIa, multi-centre trial to assess safety, tolerability, and imm … Pending
  2024-515627-10-00 7 "generalised myasthenia gravis"
• Comparative Efficacy of Nipocalimab and Efgartigimod in Myasthenia Gravis Study ID: 80202135MYG3002 EPIC Pending
  2025-521130-28-00 5 "generalized myasthenia gravis"
• A Phase 1b/2, Multicenter, Randomized, Double-blind, Placebo-controlled Study of IM-101 in Adult Participants with Generalized Myasthenia Gr … Pending
  2025-522406-20-00 9 "Generalized Myasthenia Gravis and Ocular Myasthenia Gravis"
• An open label, randomized, multiple-dose, two-treatment, two-period, cross-over bioequivalence study comparing Pyridostigmine Bromide, P.R.T … Pending
  2025-524219-35-00 2 "treatment of myasthenia gravis"
• A Double-Blind, Randomized, Placebo-Controlled Study to Investigate the Safety and Efficacy of Aritinercept, a Dual BAFF/APRIL Inhibitor, in … Pending
  2025-525127-27-00 9 "Generalized Myasthenia Gravis"
• A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis Recruiting
  2025-523950-15-01 4 2026-05-29 "Generalized Myasthenia Gravis"
• An Open-label Study to evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in children with gMG Recruiting
  2025-520993-20-00 4 2026-05-19 "Generalized Myasthenia Gravis"
• MP: ADAPT Forward - Master protocol of a platform study to evaluate the safety and efficacy of multiple regimens in participants with Myasth … Recruiting
  2025-522492-28-00 4 2026-03-13 "AChR-Ab Seropositive Generalized Myasthenia Gravis, Myasthen"
• Efficacy and Safety of a New Formulation of Oral Cladribine Compared with Placebo in Participants with Generalized Myasthenia Gravis (MyCla … Recruiting
  2023-507746-83-00 5 2024-11-27 "Generalized Myasthenia Gravis"
• A Phase 2 study of DNTH103 in patients with Generalized Myasthenia Gravis Recruiting
  2024-512865-15-00 4 2024-09-03 "Generalized Myasthenia Gravis"
• Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients with Myasthenia Gravis Recruiting
  2023-507539-40-00 4 2024-07-19 "Myasthenia Gravis"
• Evaluating Long-term Safety of Efgartigimod Administered Intravenously and Subcutaneously in Children With Generalized Myasthenia Gravis (AD … Recruiting
  2023-507379-23-00 10 2022-08-18 "Generalized Myasthenia Gravis"
• Not Applicable Recruiting
  2024-511198-31-00 10 2026-03-24 "Lupus Nephritis"
• A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Descartes-08 in Patients With Generalized Myasthenia Gravis (MG) Recruiting
  2024-520355-25-00 5 2025-10-10 "generalized myasthenia gravis"
• A study to learn how safe zilucoplan is in children with generalized myasthenia gravis who participated in a previous study about zilucoplan Recruiting
  2022-502073-42-00 5 2025-08-18 "Generalized Myasthenia Gravis"
• An open-label study to assess safety, efficacy, and cellular kinetics of YTB323 in treatment-resistant generalized myasthenia gravis Recruiting
  2024-513589-20-00 9 2025-07-29 "Treatment-resistant generalized Myasthenia Gravis"
• A study to learn how zilucoplan moves throughout the body over time and how safe it is in children with generalized myasthenia gravis Recruiting
  2022-502072-23-00 10 2025-07-11 "Generalized Myasthenia Gravis"
• A randomized, double-blind, placebo-controlled phase III study to evaluate the efficacy, safety, and tolerability of remibrutinib in patient … Recruiting
  2023-510026-32-00 5 2025-06-11 "Generalized Myasthenia Gravis"
• An extension study to find out if multiple treatment cycles of rozanolixizumab are safe and work in children with myasthenia gravis Recruiting
  2022-502075-34-00 5 2024-10-08 "Generalized Myasthenia Gravis"
• A study of efgartigimod PH20 SC in children between 2 and less than 18 years of age with generalized myasthenia gravis Recruiting
  2023-506159-12-00 10 2024-09-06 "Generalized Myasthenia Gravis"
• A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Subjects With Generalized Myasthenia Gravis Recruiting
  2023-509892-17-00 10 2024-07-09 "Generalized myasthenia gravis"
• A study to learn if rozanolixizumab is safe, how it moves through the body, and if it works in children with myasthenia gravis Recruiting
  2022-502074-16-00 10 2024-06-14 "Generalized Myasthenia Gravis"
• An Open-Label Uncontrolled Multicenter Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Activity of Nipocalimab in Child … Recruiting
  2022-502539-21-00 10 2022-10-21 "Myasthenia gravis (MG)"
• Efficacy and Safety Study of Nipocalimab IV Infusions for Adults With Generalized Myasthenia Gravis Recruiting
  2023-504152-97-00 5 2021-11-26 "Generalized Myasthenia Gravis"

Showing 1–24 of 37 trials